These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 35189650)

  • 21. Molecular characterization of a novel homozygous deletion in β-globin cluster causing (δβ)
    Kalai M; Moumni I; Ouragini H; Ben Fraj I; Mellouli F; Ouederni M; Chaouachi D; Boudriga I; Menif S
    Ann Clin Biochem; 2023 Mar; 60(2):81-85. PubMed ID: 36214153
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of Assorted Globin Haplotypes and α-Thalassemia on the Clinical Heterogeneity of Hb S-β-Thalassemia.
    Dash PM; Sahu PK; Patel S; Mashon RS; Kharat KR; Mukherjee MB
    Hemoglobin; 2018 Jul; 42(4):236-242. PubMed ID: 30486691
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular Understanding of Severe Cases of β-Thalassemia in the Nablus Region, West Bank, Palestine.
    Samha L; Sirdah MM; Reading NS; Karmi B; Agarwal AM
    Hemoglobin; 2020 Mar; 44(2):128-130. PubMed ID: 32420772
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Molecular genetic characteristics of a family which coinheritance of rare-88 C>G (
    Li W; Chen LT; Yu Y; Wang J; Li CY; Cai TE; Lu CJ; Li DX; Tian XJ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2023 Feb; 57(2):253-258. PubMed ID: 36797585
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comprehensive analysis of mitochondrial and nuclear DNA variations in patients affected by hemoglobinopathies: A pilot study.
    Barbanera Y; Arcioni F; Lancioni H; La Starza R; Cardinali I; Matteucci C; Nofrini V; Roetto A; Piga A; Grammatico P; Caniglia M; Mecucci C; Gorello P
    PLoS One; 2020; 15(10):e0240632. PubMed ID: 33091040
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hb H disease with various β hemoglobinopathies: molecular, hematological and diagnostic aspects.
    Fucharoen S; Fucharoen G
    Hemoglobin; 2012; 36(1):18-24. PubMed ID: 22145566
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The epidemiologic transition of thalassemia and associated hemoglobinopathies in southern Taiwan.
    Wang HC; Hsieh LL; Liu YC; Hsiao HH; Lin SK; Tsai WC; Liu TC
    Ann Hematol; 2017 Feb; 96(2):183-188. PubMed ID: 27891555
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Changes in hemoglobin in patients with hemolytic anemia].
    Pérez G; de la Peña ME; Esparza A; Mejía A; Vázquez V; Aguilar Luna JC; González J; López-Guido B; Ornelas ML; Ibarra B
    Arch Invest Med (Mex); 1990; 21(4):385-8. PubMed ID: 1669229
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reticulocyte hemoglobin equivalent to detect thalassemia and thalassemic hemoglobin variants.
    Sudmann ÅA; Piehler A; Urdal P
    Int J Lab Hematol; 2012 Dec; 34(6):605-13. PubMed ID: 22765164
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular Basis and Hematologic Phenotype of Hemoglobin H Disease Combined with Two Rare β-Globin Mutations.
    Qiu Y; Wei S; Hou W; Lai K; Zhu H; Li W; Li Q; Yang Z; Shu Q; Chen P; Mo W
    Hemoglobin; 2023 Nov; 47(2):52-55. PubMed ID: 37309066
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Spectrum of hemoglobinopathies in the state of Orissa, India: a ten years cohort study.
    Balgir RS
    J Assoc Physicians India; 2005 Dec; 53():1021-6. PubMed ID: 16572956
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidemiology of Hemoglobinopathies in the Huzhou Region, Zhejiang Province, Southeast China.
    Ding ZY; Shen GS; Zhang S; He PY
    Hemoglobin; 2016 Sep; 40(5):304-309. PubMed ID: 27615034
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Detection of beta thalassemia by the technique of refractory amplification of mutation systems (ARMS-PCR)].
    Bravo M; Salazar R; Arends A; Alvarez M; Velázquez D; Guevara JM; Castillo O
    Invest Clin; 1999 Sep; 40(3):203-13. PubMed ID: 10531753
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coinheritance of alpha-thalassemia-1 and hemoglobin E/beta zero-thalassemia: practical implications for neonatal screening and genetic counseling.
    Krishnamurti L; Chui DH; Dallaire M; LeRoy B; Waye JS; Perentesis JP
    J Pediatr; 1998 May; 132(5):863-5. PubMed ID: 9602201
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elevated Hb A₂ Levels in a Patient with a Compound Heterozygosity for the (β⁺) -31 (A > G) and (β⁰) Codon 17 (A > T) Mutations Together with a Single α-Globin Gene.
    Panyasai S; Jaiping K; Pornprasert S
    Hemoglobin; 2015; 39(4):292-5. PubMed ID: 26029792
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Severe Thalassemia Caused by Hb Zunyi [β147(HC3)Stop→Gln;
    Su Q; Chen S; Wu L; Tian R; Yang X; Huang X; Chen Y; Peng Z; Chen J
    Hemoglobin; 2019 Jan; 43(1):7-11. PubMed ID: 31084366
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comprehensive screening program for β-thalassemia and other hemoglobinopathies in the Hooghly District of West Bengal, India, dealing with 21 137 cases.
    Bhattacharyya KK; Chatterjee T; Mondal UB
    Hemoglobin; 2016 Nov; 40(6):396-399. PubMed ID: 28276872
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Premarital hemoglobinopathy screening in Kayseri: a city in Middle Anatolia region of Turkey.
    Karakukcu C; Kocer D; Altuner Torun Y; Karakukcu M; Yokus O; Ozdemir MA; Patiroglu T
    J Pediatr Hematol Oncol; 2012 Mar; 34(2):e49-52. PubMed ID: 22246155
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of thalassemia in patients with microcytosis referred for hemoglobinopathy investigation in Ontario: a prospective cohort study.
    Lafferty JD; Barth DS; Sheridan BL; McFarlane AG; Halchuk LM; Crowther MA
    Am J Clin Pathol; 2007 Feb; 127(2):192-6. PubMed ID: 17210523
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preventation of thalassemia in Australia.
    Hendy J
    Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 2():94-6. PubMed ID: 11400797
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.